Evidence for a peripheral mechanism of action for the potentiation of the antinociceptive effect of morphine by dipyrone

Journal of Pharmacological and Toxicological Methods

Volumn 42, Issue 2, 1999, Pages 79-85

  Aguirre Bañuelos, Patricia ^a   Granados Soto, Vinicio ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Cyclic GMP; Dipyrone; L NAME; Morphine; Naloxone; Nitric oxide

Indexed keywords

CYCLIC GMP; DIPYRONE; FORMALDEHYDE; MORPHINE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; SODIUM CHLORIDE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; NONHUMAN; PAIN; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLIC GMP; DIPYRONE; DRUG SYNERGISM; FEMALE; MORPHINE; NALOXONE; NARCOTICS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0342656585     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(00)00046-0     Document Type: Article

References (34)

1. Abbate R., Gori A.M., Pinto S., Attanasio M., Paniccia R., Coppo M., Castellani S., Giusti B., Boddi M., Neri S.G.G. Cycloxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils. in vitro effect of dipyrone Prostaglandins Leukot Essent Fatty Acids. 41:1990;89-93.
2. Beirith A., Santos A.R.S., Rodrigues A.L.S., Creczynski-Pasa T.B., Calixto J.B. Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. study of the mechanism of action Eur J Pharmacol. 345:1998;233-245.
3. Campos C., de Gregorio R., García-Nieto R., Gago F., Ortiz P., Alemany S. Regulation of cyclooxygenase activity by metamizol. Eur J Pharmacol. 378:1999;339-347.
4. Carlsson K.H., Jurna I. The role of descending inhibition in the antinociceptive effects of the pyrazolone derivatives, metamizole (dipyrone) and aminophenazone (Piramidon). Naunyn-Schmiedebergs's Arch Pharmacol. 335:1987;149-154.
5. Carlsson K.H., Helmreich J., Jurna I. The activation of inhibition from the periacueductal gray matter mediates central analgesic effect of metamizole (dipyrone). Pain. 27:1986;373-390.
6. Carlsson K.H., Monzel W., Jurna I. Depression by morphine and the non-opioid analgesic agents, metamizol (dipyrone), lysine acetylsalicylate and paracetamol, of activity in the rat thalamus neurons evoked by electrical stimulation of nociceptive afferents. Pain. 32:1988;313-326.
7. Dembinska-Kiec A., Zmuda A., Krupinska I. Inhibition of prostaglandin synthetase by aspirin-like drugs in different microsomal preparations. Advances in Prostaglandin and Thromboxane Research 1. Eds., B. Samuelsson & R. Paoletti. New York: Raven Press. 1976;99-118.
8. Duarte I.D., Santos I.R., Lorenzetti B.B., Ferreira S.H. Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur J Pharmacol. 217:1992;225-227.
9. Ferreira S.H. Prostaglandins, aspirin-like drugs and analgesia. Nature. 240:1972;200-203.
10. Ferreira S.H., Moncada S., Vane J.R. Indomethacin and aspirin abolish the prostaglandin release from the spleen. Nat New Biol. 231:1971;237-239.
11. Ferreira S.H., Lorenzetti B.B., Correa F.M.A. Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol. 53:1978;39-48.
12. Gelgor L., Cartmell S., Mitchell D. Intracerebroventricular micro-injections of non-steroidal anti-inflammatory drugs abolish reperfusion hyperalgesia in the rat's tail. Pain. 50:1992;323-329.
13. Granados-Soto V., Flores-Murrieta F.J., Castañeda-Hernández G., López-Muñoz F.J. Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac in the rat. Eur J Pharmacol. 277:1995;281-284.
14. Granados-Soto V., Rufino M.O., Gomes Lopes L.D., Ferreira S.H. Evidence for the involvement of nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur J Pharmacol. 287:1997;281-284.
15. Ethical guidelines for investigations on experimental pain in conscious animals. Pain. 16:1983;109-110.
16. Laird J.M.A., Roza C., Olivar T. Antinociceptive activity of metamizol in rats with experimental ureteric calculosis. central and peripheral components Inflamm Res. 47:1998;389-395.
17. Levine J.D., Taiwo Y.O. Involvement of the mu-opiate receptor in peripheral analgesia. Neuroscience. 32:1989;571-575.
18. Lim R.K.S., Guzman F., Rodgers D.W., Goto K., Braun C., Dickerson G.D., Engle R.J. Site of action of narcotic and non-narcotic analgesics determined by blocking bradykinin-evoked visceral pain. Arch Int Pharmacodyn Ther. 152:1964;25-58.
19. López-Muñoz F.J. Surface of synergistic interaction between dipyrone and morphine in the PIFIR model. Drug Develop Res. 33:1994;26-32.
20. Lorenzetti B.B., Ferreira S.H. Mode of analgesic action of dipyrone. direct antagonism of inflammatory hyperalgesia Eur J Pharmacol. 114:1985;375-381.
21. Lorenzetti B.B., Ferreira S.H. Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia. Inflamm Res. 45:1996;308-311.
22. Malmberg A.B., Yaksh T.L. Antinociceptive actions of spinal non-steroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther. 263:1992;136-146.
23. Malmberg A.B., Yaksh T.L. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology. 79:1993;270-281.
24. Maves T.J., Pechman P.S., Meller S.T., Gebhart G.F. Ketorolac potentiates morphine antinociception during visceral nociception in the rat. Anesthesiology. 80:1994;1094-1101.
25. Rockeman M.G., Seeling W., Bischof C., Borstinghaus D., Steffen P., Georgieff M. Prophylactic use of epidural mepivacaine/morphine, systemic diclofenac and metamizole on postoperative morphine consumption after major abdominal surgery. Anesthesiology. 84:1996;1027. (abstract).
26. Shimada S.G., Otterness I.G., Stitt J.T. A study of the mechanism of action of the mild analgesic dipyrone. Agents Actions. 41:1994;188-192.
27. Stein C., Millan M.J., Shippenberg T.S., Peter K., Herz A. Peripheral opioid receptors mediating antinociception in inflammation. evidence for involvement of mu, delta and kappa receptors J Pharmacol Exp Ther. 248:1989;1269-1275.
28. Taylor J., Mellstrom B., Fernaud I., Naranjo J.R. Metamizol potentiates morphine effects on visceral pain and evoked c-Fos immunoreactivity in spinal cord. Eur J Pharmacol. 351:1998;39-47.
29. Tempel G., von Hundelshausen B., Reecker W. The opiate-sparing effect of dipyrone in post-operative pain therapy with morphine using a patient-controlled analgesic system. Care Med. 22:1996;1043-1047.
30. Tonussi C.R., Ferreira S.H. Mechanism of diclofenac analgesia. direct blockade of inflammatory sensitization Eur J Pharmacol. 251:1994;173-179.
31. Tortorici V., Vanegas H. Putative role of medullary off- and on-cells in the antinociception produced by dipyrone (metamizol) administered systematically or microinjected into PAG. Pain. 57:1994;197-205.
32. Tortorici V., Vasquez E., Vanegas H. Naloxone partial reversal of the antinociception produced by dipyrone microinjected into periaqueductal gray of rats. possible involvement of medullary off- and on-cells Brain Res. 725:1996;106-110.
33. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. 231:1971;232-235.
34. Vlaskovska M., Surcheva S., Ovcharov R. Importance of endogenous opioids and prostaglandins in the action of analgin (metamizole) and verapamil. Farmakol Toksikol. 52:1989;25-29.